BY OUR PLATFORMS
BY THERAPEUTIC AREA
13 June 2017
From the beginning, ZeClinics, has always been interested in enter into emerging markets where biotechnology needs are crucial. One of the most interesting, because of its unstoppable growth potential, is the Asian market. However, in turn, is one of the most complex and difficult markets to access, due to the inter-cultural differences and its lack of permeability to new products and services from abroad.
Therefore, it is our pleasure to announce the alliance between ZeClinics and one strategic partner in Japan, Three S Japan Co.
Three S Japan Co., Ltd, is a Japanese company based in Tokyo with a team of professionals well versed in pre-clinical and clinical trials of pharmaceutical products development. They are able to prepare the support system with various services such as, designing test plan, analysis and collation of data, evaluation of related papers, and drafting application forms for pharmaceutical products, medical equipment, unregulated drugs, cosmetics, among others.
This alliance can easily promote ZeClinics to enter the competitive Asian market successfully.